BCSC Halts Trading in Noveris Health Sciences Inc. Securities

BCSC News Releases

Filed March 25th, 2026

Detected March 26th, 2026

Summary

The BC Securities Commission (BCSC) has halted trading in Noveris Health Sciences Inc. securities until April 16, 2026. The order was issued due to unexplained trading volume and price fluctuations, discrepancies between offering documents and financial statements, and misleading promotional articles.

View original document View source feed page

What changed

The executive director of the BC Securities Commission (BCSC) has issued a trading halt order for Noveris Health Sciences Inc. securities, effective March 25, 2026, and lasting until April 16, 2026. This action was prompted by significant and unexplained increases in trading volume and share price, as well as concerns regarding inconsistencies between the company's offering document and its financial statements, and the presence of misleading promotional articles. The order specifically addresses unusual trading activity between March 13 and March 19, 2026, where the share price surged 423% and daily trading volume increased dramatically.

This halt trade order requires immediate attention from Noveris Health Sciences Inc. and any investors holding its securities. While the order is initially for 15 business days, it can be extended. The BCSC's action signals a serious concern about market integrity and investor protection related to Noveris. Companies and their legal counsel should review their disclosures and promotional materials for accuracy and compliance with securities regulations to avoid similar regulatory scrutiny. The BCSC is focused on maintaining a fair and orderly market, and non-compliance can lead to significant penalties and reputational damage.

What to do next

Review Noveris Health Sciences Inc. disclosures and financial statements for discrepancies.
Investigate the cause of unusual trading volume and price fluctuations.
Ensure promotional materials align with official filings and contain no misleading statements.

Penalties

Halt trade orders can last no more than 15 business days, although they can be extended.

Source document (simplified)

About Find more about Media Room

News Release

BCSC issues halt trade order on B.C.-based Noveris Health Sciences Inc.

### Date:

2026-03-25
- ### Number:

2026/018

Vancouver – The executive director of the BC Securities Commission (BCSC) has halted trading in Noveris Health Sciences Inc. securities due to unusual, unexplained fluctuations in trading volume and market price and concerns about orderly trading.

The share price of Noveris on the Canadian Securities Exchange increased 423 per cent, from $0.42 to $2.20, between March 13 and March 19. Its average daily trading volume between March 16 and March 19 was nearly 200,000 shares traded, compared to a previous 30-day average of approximately 6,000 shares traded. Noveris also trades on the Frankfurt Stock Exchange and is quoted on U.S. over-the-counter markets.

In addition, BCSC staff informed the BCSC’s executive director that some statements in the company’s March 11 offering document do not align with statements in its most recent financial statements, filed in November last year.

BCSC staff also noted to the executive director that there are publicly available promotional articles that contain untrue and misleading statements about Noveris’s business and prospects.

Given the circumstances, the executive director halted trading in Noveris’s securities until April 16, 2026. Halt trade orders can last no more than 15 business days, although they can be extended.

About the BC Securities Commission ( bcsc.bc.ca )

The BC Securities Commission, an independent provincial government agency, strives to make the investment market benefit the public. We set rules, monitor compliance by industry, take action against misconduct, and provide guidance to investors and industry. As guardians of B.C.’s investment market, we’re committed to maintaining a market that is honest, fair, competitive and dynamic, enabling British Columbians to thrive.

Media Contact:
Elise Palmer
604-899-6830

Public inquiries:
604-899-6854 or 1-800-373-6393 (toll free)
inquiries@bcsc.bc.ca

Learn how to protect yourself and become a more informed investor at www.investright.org